Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infant, Premature | 143 | 2024 | 2041 | 13.350 |
Why?
|
Infant, Premature, Diseases | 48 | 2023 | 706 | 7.370 |
Why?
|
Hypoxia-Ischemia, Brain | 39 | 2023 | 326 | 5.970 |
Why?
|
Brain Injuries | 40 | 2024 | 2024 | 5.010 |
Why?
|
Infant, Newborn | 288 | 2024 | 25575 | 4.690 |
Why?
|
Developmental Disabilities | 45 | 2019 | 1452 | 4.550 |
Why?
|
Intensive Care Units, Neonatal | 34 | 2023 | 778 | 4.530 |
Why?
|
Brain | 130 | 2024 | 26343 | 4.300 |
Why?
|
Infant, Very Low Birth Weight | 36 | 2023 | 406 | 4.140 |
Why?
|
Premature Birth | 35 | 2024 | 1713 | 3.910 |
Why?
|
Brain Diseases | 24 | 2023 | 1554 | 3.430 |
Why?
|
Infant, Newborn, Diseases | 21 | 2023 | 580 | 3.310 |
Why?
|
Hypothermia, Induced | 25 | 2023 | 747 | 3.050 |
Why?
|
Magnetic Resonance Imaging | 158 | 2024 | 35342 | 2.960 |
Why?
|
Gestational Age | 68 | 2024 | 3490 | 2.800 |
Why?
|
Infant Behavior | 12 | 2014 | 156 | 2.780 |
Why?
|
Child Development | 35 | 2021 | 2222 | 2.600 |
Why?
|
Leukomalacia, Periventricular | 13 | 2023 | 183 | 2.480 |
Why?
|
Neurologic Examination | 15 | 2023 | 931 | 1.670 |
Why?
|
Milk, Human | 4 | 2022 | 490 | 1.650 |
Why?
|
Asphyxia Neonatorum | 11 | 2021 | 107 | 1.640 |
Why?
|
Infant | 90 | 2024 | 35070 | 1.490 |
Why?
|
Intensive Care, Neonatal | 12 | 2019 | 197 | 1.410 |
Why?
|
Nerve Fibers, Myelinated | 11 | 2013 | 960 | 1.380 |
Why?
|
Cerebral Ventricles | 13 | 2022 | 544 | 1.320 |
Why?
|
Diffusion Magnetic Resonance Imaging | 26 | 2023 | 2736 | 1.320 |
Why?
|
Echoencephalography | 7 | 2022 | 135 | 1.300 |
Why?
|
Fetal Growth Retardation | 8 | 2023 | 570 | 1.300 |
Why?
|
Ductus Arteriosus, Patent | 7 | 2022 | 209 | 1.230 |
Why?
|
Electroencephalography | 27 | 2022 | 6142 | 1.220 |
Why?
|
Hypoxia, Brain | 4 | 2014 | 133 | 1.170 |
Why?
|
Diffusion Tensor Imaging | 18 | 2022 | 2304 | 1.140 |
Why?
|
Cerebral Cortex | 26 | 2019 | 5705 | 1.130 |
Why?
|
Cerebral Hemorrhage | 20 | 2022 | 2643 | 1.090 |
Why?
|
Intracranial Hemorrhages | 5 | 2015 | 854 | 1.010 |
Why?
|
Leukoencephalopathies | 5 | 2015 | 238 | 0.950 |
Why?
|
Cerebral Palsy | 7 | 2014 | 459 | 0.940 |
Why?
|
Humans | 319 | 2024 | 742088 | 0.920 |
Why?
|
Papio | 15 | 2011 | 656 | 0.920 |
Why?
|
Longitudinal Studies | 44 | 2023 | 13921 | 0.890 |
Why?
|
Brain Damage, Chronic | 6 | 2013 | 265 | 0.880 |
Why?
|
Head | 6 | 2022 | 878 | 0.870 |
Why?
|
Seizures | 14 | 2023 | 2851 | 0.850 |
Why?
|
Organ Size | 18 | 2020 | 2253 | 0.850 |
Why?
|
Female | 205 | 2024 | 379592 | 0.840 |
Why?
|
Maternal Behavior | 4 | 2013 | 311 | 0.820 |
Why?
|
Hydrocephalus | 8 | 2021 | 746 | 0.730 |
Why?
|
Male | 175 | 2023 | 349538 | 0.720 |
Why?
|
Mothers | 3 | 2019 | 2163 | 0.720 |
Why?
|
Bronchopulmonary Dysplasia | 5 | 2013 | 306 | 0.710 |
Why?
|
Corpus Callosum | 7 | 2015 | 737 | 0.700 |
Why?
|
Caffeine | 3 | 2022 | 699 | 0.680 |
Why?
|
Hippocampus | 9 | 2017 | 3661 | 0.650 |
Why?
|
Cognition Disorders | 9 | 2015 | 4030 | 0.650 |
Why?
|
Anesthesia | 3 | 2019 | 1548 | 0.640 |
Why?
|
Patients' Rooms | 2 | 2023 | 63 | 0.630 |
Why?
|
Language Disorders | 2 | 2016 | 140 | 0.620 |
Why?
|
Fentanyl | 3 | 2023 | 410 | 0.620 |
Why?
|
Cerebellum | 6 | 2018 | 1490 | 0.620 |
Why?
|
Psychomotor Disorders | 2 | 2016 | 152 | 0.610 |
Why?
|
Lipid Peroxidation | 7 | 2004 | 270 | 0.600 |
Why?
|
Executive Function | 4 | 2017 | 1362 | 0.600 |
Why?
|
Prospective Studies | 53 | 2022 | 53187 | 0.590 |
Why?
|
Anisotropy | 16 | 2016 | 1265 | 0.580 |
Why?
|
Term Birth | 10 | 2016 | 135 | 0.580 |
Why?
|
Erythropoietin | 1 | 2021 | 724 | 0.570 |
Why?
|
Pregnancy | 38 | 2023 | 29087 | 0.560 |
Why?
|
Cerebrum | 3 | 2014 | 137 | 0.560 |
Why?
|
Occipital Lobe | 7 | 2019 | 380 | 0.560 |
Why?
|
Heart Defects, Congenital | 6 | 2019 | 4566 | 0.550 |
Why?
|
Fetal Blood | 9 | 2021 | 1317 | 0.530 |
Why?
|
Parents | 5 | 2023 | 3387 | 0.530 |
Why?
|
Child, Preschool | 46 | 2021 | 40955 | 0.520 |
Why?
|
Neonatology | 3 | 2020 | 121 | 0.510 |
Why?
|
Morphine | 2 | 2020 | 657 | 0.510 |
Why?
|
Therapeutic Touch | 1 | 2014 | 8 | 0.500 |
Why?
|
Body Composition | 3 | 2022 | 2400 | 0.500 |
Why?
|
Image Interpretation, Computer-Assisted | 8 | 2016 | 3328 | 0.490 |
Why?
|
Point-of-Care Systems | 6 | 2015 | 1175 | 0.480 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.450 |
Why?
|
Mother-Child Relations | 4 | 2013 | 481 | 0.450 |
Why?
|
Chorioamnionitis | 1 | 2014 | 155 | 0.450 |
Why?
|
Child Language | 4 | 2018 | 64 | 0.450 |
Why?
|
Acidosis | 2 | 2016 | 272 | 0.440 |
Why?
|
Anticonvulsants | 4 | 2023 | 1914 | 0.440 |
Why?
|
Conscious Sedation | 1 | 2017 | 528 | 0.430 |
Why?
|
Analgesia | 1 | 2017 | 459 | 0.430 |
Why?
|
Hypnotics and Sedatives | 3 | 2023 | 1158 | 0.430 |
Why?
|
Ferrets | 2 | 2011 | 194 | 0.430 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2021 | 2552 | 0.430 |
Why?
|
Stress, Psychological | 5 | 2020 | 4229 | 0.420 |
Why?
|
Imaging, Three-Dimensional | 10 | 2019 | 4029 | 0.420 |
Why?
|
Birth Injuries | 1 | 2013 | 148 | 0.420 |
Why?
|
Sepsis | 3 | 2020 | 2589 | 0.410 |
Why?
|
Fetal Diseases | 3 | 2021 | 903 | 0.410 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2020 | 941 | 0.410 |
Why?
|
Infant, Low Birth Weight | 6 | 2021 | 850 | 0.410 |
Why?
|
Monitoring, Physiologic | 6 | 2022 | 1737 | 0.400 |
Why?
|
Image Processing, Computer-Assisted | 21 | 2021 | 8925 | 0.400 |
Why?
|
Child | 54 | 2022 | 77478 | 0.390 |
Why?
|
Relaxation Therapy | 1 | 2012 | 178 | 0.390 |
Why?
|
Posture | 1 | 2016 | 958 | 0.390 |
Why?
|
Neuropsychological Tests | 20 | 2020 | 6974 | 0.390 |
Why?
|
Cerebral Infarction | 3 | 2007 | 1007 | 0.390 |
Why?
|
Apgar Score | 4 | 2021 | 123 | 0.390 |
Why?
|
Victoria | 5 | 2018 | 67 | 0.390 |
Why?
|
Brain Mapping | 14 | 2021 | 6669 | 0.380 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2021 | 340 | 0.380 |
Why?
|
Basal Ganglia | 5 | 2020 | 545 | 0.380 |
Why?
|
Language Development | 5 | 2017 | 187 | 0.380 |
Why?
|
Emotional Intelligence | 1 | 2012 | 135 | 0.370 |
Why?
|
Bacteremia | 2 | 2014 | 962 | 0.370 |
Why?
|
Birth Weight | 8 | 2020 | 2068 | 0.370 |
Why?
|
Sodium Bicarbonate | 1 | 2010 | 62 | 0.370 |
Why?
|
Respiration, Artificial | 8 | 2020 | 2566 | 0.360 |
Why?
|
Prognosis | 23 | 2021 | 29010 | 0.360 |
Why?
|
Internal Capsule | 4 | 2015 | 113 | 0.350 |
Why?
|
Memory Disorders | 4 | 2014 | 1183 | 0.350 |
Why?
|
Autistic Disorder | 3 | 2015 | 1174 | 0.340 |
Why?
|
Linear Models | 13 | 2018 | 5948 | 0.330 |
Why?
|
Sensitivity and Specificity | 16 | 2021 | 14720 | 0.330 |
Why?
|
Malformations of Cortical Development | 1 | 2011 | 200 | 0.320 |
Why?
|
Reproducibility of Results | 15 | 2023 | 19862 | 0.320 |
Why?
|
Intelligence | 5 | 2020 | 920 | 0.320 |
Why?
|
Diagnostic Techniques, Neurological | 1 | 2008 | 65 | 0.320 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 2022 | 3760 | 0.320 |
Why?
|
Thalamus | 5 | 2020 | 1023 | 0.320 |
Why?
|
Retinopathy of Prematurity | 5 | 2021 | 421 | 0.320 |
Why?
|
Breast Feeding | 1 | 2016 | 1339 | 0.310 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2021 | 347 | 0.310 |
Why?
|
Transportation of Patients | 3 | 2011 | 185 | 0.310 |
Why?
|
Depression, Postpartum | 1 | 2012 | 339 | 0.300 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.290 |
Why?
|
Oxygen | 7 | 2022 | 4169 | 0.290 |
Why?
|
Fetal Hypoxia | 2 | 2012 | 29 | 0.290 |
Why?
|
Follow-Up Studies | 26 | 2020 | 39004 | 0.290 |
Why?
|
Regression Analysis | 9 | 2020 | 6452 | 0.280 |
Why?
|
Nervous System | 2 | 2008 | 553 | 0.280 |
Why?
|
Neural Cell Adhesion Molecule L1 | 4 | 2021 | 40 | 0.270 |
Why?
|
Hydrocortisone | 2 | 2014 | 1825 | 0.270 |
Why?
|
Wallerian Degeneration | 1 | 2006 | 70 | 0.270 |
Why?
|
Disease Models, Animal | 12 | 2011 | 18006 | 0.270 |
Why?
|
Brain Ischemia | 5 | 2007 | 3258 | 0.260 |
Why?
|
Meningitis, Escherichia coli | 1 | 2004 | 2 | 0.260 |
Why?
|
Surgical Procedures, Operative | 2 | 2020 | 1873 | 0.260 |
Why?
|
Hypotension | 2 | 2023 | 880 | 0.260 |
Why?
|
Movement | 3 | 2009 | 1470 | 0.250 |
Why?
|
Status Epilepticus | 1 | 2010 | 444 | 0.250 |
Why?
|
Parenting | 4 | 2020 | 676 | 0.250 |
Why?
|
Cohort Studies | 25 | 2021 | 40450 | 0.250 |
Why?
|
Severity of Illness Index | 17 | 2022 | 15530 | 0.250 |
Why?
|
Amyloid beta-Protein Precursor | 5 | 2021 | 1121 | 0.250 |
Why?
|
New Zealand | 9 | 2015 | 357 | 0.250 |
Why?
|
Cerebrospinal Fluid Shunts | 2 | 2021 | 189 | 0.250 |
Why?
|
Sodium | 1 | 2010 | 1627 | 0.250 |
Why?
|
Free Radicals | 4 | 2002 | 236 | 0.250 |
Why?
|
Cephalometry | 3 | 2020 | 382 | 0.250 |
Why?
|
Cerebrovascular Circulation | 4 | 2022 | 2732 | 0.250 |
Why?
|
Algorithms | 10 | 2020 | 13853 | 0.240 |
Why?
|
Memory, Short-Term | 4 | 2016 | 972 | 0.240 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2012 | 1538 | 0.240 |
Why?
|
Estradiol | 2 | 2014 | 2021 | 0.240 |
Why?
|
Animals, Newborn | 11 | 2010 | 2723 | 0.240 |
Why?
|
Predictive Value of Tests | 14 | 2015 | 15056 | 0.240 |
Why?
|
Vision Disorders | 2 | 2013 | 1057 | 0.240 |
Why?
|
Incontinentia Pigmenti | 1 | 2003 | 10 | 0.240 |
Why?
|
Hypoglycemia | 2 | 2008 | 859 | 0.230 |
Why?
|
Language | 5 | 2021 | 1458 | 0.230 |
Why?
|
Parenteral Nutrition, Total | 3 | 2020 | 300 | 0.230 |
Why?
|
Hypocapnia | 2 | 2022 | 34 | 0.230 |
Why?
|
Goals | 2 | 2020 | 705 | 0.230 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3667 | 0.230 |
Why?
|
Neural Pathways | 7 | 2019 | 2971 | 0.230 |
Why?
|
Noise, Transportation | 1 | 2003 | 50 | 0.220 |
Why?
|
Retrospective Studies | 21 | 2023 | 77098 | 0.220 |
Why?
|
Patient Acceptance of Health Care | 2 | 2016 | 3014 | 0.220 |
Why?
|
Paralysis | 1 | 2004 | 249 | 0.220 |
Why?
|
Neurology | 1 | 2011 | 762 | 0.220 |
Why?
|
Tomography, Optical | 2 | 2015 | 126 | 0.220 |
Why?
|
Nervous System Diseases | 2 | 2011 | 1617 | 0.220 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2014 | 3649 | 0.220 |
Why?
|
Psychomotor Performance | 6 | 2011 | 1895 | 0.220 |
Why?
|
Social Behavior | 4 | 2015 | 1128 | 0.220 |
Why?
|
Risk Factors | 24 | 2022 | 72145 | 0.220 |
Why?
|
Dilatation, Pathologic | 6 | 2012 | 520 | 0.210 |
Why?
|
Progestins | 1 | 2004 | 303 | 0.210 |
Why?
|
Pilot Projects | 5 | 2019 | 8297 | 0.210 |
Why?
|
Patient Discharge | 4 | 2018 | 3300 | 0.210 |
Why?
|
Infant Care | 3 | 2013 | 183 | 0.210 |
Why?
|
Models, Animal | 3 | 2005 | 2170 | 0.210 |
Why?
|
Fetal Development | 2 | 2021 | 767 | 0.210 |
Why?
|
Lung Diseases | 5 | 2009 | 1884 | 0.210 |
Why?
|
Food, Fortified | 2 | 2021 | 191 | 0.210 |
Why?
|
Central Nervous System Stimulants | 1 | 2010 | 1148 | 0.210 |
Why?
|
Child Behavior Disorders | 5 | 2015 | 807 | 0.200 |
Why?
|
Progesterone | 2 | 2014 | 773 | 0.200 |
Why?
|
Twins | 1 | 2003 | 339 | 0.200 |
Why?
|
Cognition | 10 | 2021 | 6722 | 0.200 |
Why?
|
Ultrasonography | 6 | 2015 | 5978 | 0.200 |
Why?
|
Child Behavior | 3 | 2019 | 838 | 0.200 |
Why?
|
Diabetic Ketoacidosis | 2 | 2015 | 247 | 0.200 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2022 | 103 | 0.200 |
Why?
|
Movement Disorders | 3 | 2015 | 444 | 0.190 |
Why?
|
Leukoaraiosis | 1 | 2022 | 120 | 0.190 |
Why?
|
Body Weight | 6 | 2020 | 4664 | 0.190 |
Why?
|
Cerebral Veins | 1 | 2002 | 156 | 0.190 |
Why?
|
Australia | 5 | 2015 | 1167 | 0.180 |
Why?
|
Glucose | 3 | 2019 | 4391 | 0.180 |
Why?
|
Reading | 2 | 2021 | 557 | 0.180 |
Why?
|
Music Therapy | 1 | 2021 | 100 | 0.180 |
Why?
|
Meningitis, Bacterial | 1 | 2002 | 218 | 0.180 |
Why?
|
Thiobarbituric Acid Reactive Substances | 2 | 1996 | 46 | 0.180 |
Why?
|
Visual Cortex | 4 | 2012 | 1149 | 0.180 |
Why?
|
Oxidative Stress | 4 | 2012 | 3081 | 0.170 |
Why?
|
Emotions | 4 | 2020 | 2657 | 0.170 |
Why?
|
Temporal Lobe | 3 | 2023 | 1669 | 0.170 |
Why?
|
Iatrogenic Disease | 1 | 2003 | 545 | 0.170 |
Why?
|
Fetus | 3 | 2021 | 1879 | 0.170 |
Why?
|
Sucrose | 1 | 2020 | 164 | 0.170 |
Why?
|
Memory | 3 | 2020 | 2163 | 0.170 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2017 | 721 | 0.170 |
Why?
|
Reference Values | 8 | 2014 | 4982 | 0.170 |
Why?
|
Risk Assessment | 8 | 2017 | 23320 | 0.170 |
Why?
|
Analysis of Variance | 7 | 2012 | 6365 | 0.170 |
Why?
|
Age Factors | 8 | 2021 | 18355 | 0.170 |
Why?
|
Hemodynamics | 3 | 2019 | 4197 | 0.170 |
Why?
|
Neurogenesis | 2 | 2019 | 829 | 0.170 |
Why?
|
Education, Medical, Graduate | 1 | 2011 | 2283 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 2 | 2019 | 571 | 0.170 |
Why?
|
Evoked Potentials, Visual | 2 | 2012 | 427 | 0.160 |
Why?
|
Anxiety | 2 | 2013 | 4279 | 0.160 |
Why?
|
Menstruation | 1 | 2020 | 299 | 0.160 |
Why?
|
Tomography, X-Ray Computed | 3 | 2014 | 20086 | 0.160 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2002 | 356 | 0.160 |
Why?
|
Glial Fibrillary Acidic Protein | 5 | 2011 | 524 | 0.160 |
Why?
|
Magnetic Resonance Angiography | 2 | 2003 | 1440 | 0.160 |
Why?
|
Drinking | 1 | 2019 | 197 | 0.160 |
Why?
|
Adolescent Development | 1 | 2021 | 277 | 0.160 |
Why?
|
Body Temperature | 2 | 2019 | 776 | 0.160 |
Why?
|
Time Factors | 21 | 2020 | 40054 | 0.160 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2021 | 378 | 0.160 |
Why?
|
Nitric Oxide | 1 | 2007 | 2128 | 0.160 |
Why?
|
Pregnancy Complications | 5 | 2015 | 2861 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3915 | 0.160 |
Why?
|
Reperfusion Injury | 2 | 2007 | 1025 | 0.160 |
Why?
|
Music | 1 | 2021 | 259 | 0.160 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2017 | 30 | 0.150 |
Why?
|
Attention | 2 | 2021 | 2396 | 0.150 |
Why?
|
Biometry | 2 | 2013 | 558 | 0.150 |
Why?
|
Dominance, Cerebral | 2 | 2012 | 635 | 0.150 |
Why?
|
Estrogens | 1 | 2004 | 1562 | 0.150 |
Why?
|
Mental Health | 3 | 2020 | 2997 | 0.150 |
Why?
|
Frontal Lobe | 3 | 2013 | 1407 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2015 | 3336 | 0.150 |
Why?
|
Animals | 31 | 2019 | 168561 | 0.150 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2015 | 2407 | 0.150 |
Why?
|
Patients | 1 | 2023 | 892 | 0.150 |
Why?
|
Language Development Disorders | 1 | 2018 | 196 | 0.140 |
Why?
|
Benchmarking | 1 | 2023 | 1038 | 0.140 |
Why?
|
Registries | 5 | 2023 | 8077 | 0.140 |
Why?
|
Social Environment | 2 | 2012 | 1023 | 0.140 |
Why?
|
Electrocardiography | 1 | 2010 | 6440 | 0.140 |
Why?
|
Motor Skills | 4 | 2015 | 518 | 0.140 |
Why?
|
Maternal Age | 1 | 2019 | 802 | 0.140 |
Why?
|
Nystagmus, Physiologic | 1 | 2015 | 29 | 0.130 |
Why?
|
Oligodendroglia | 5 | 2011 | 514 | 0.130 |
Why?
|
Functional Laterality | 4 | 2015 | 2290 | 0.130 |
Why?
|
Parent-Child Relations | 3 | 2015 | 747 | 0.130 |
Why?
|
Clinical Competence | 1 | 2011 | 4681 | 0.130 |
Why?
|
Astrocytes | 6 | 2017 | 1266 | 0.130 |
Why?
|
Family | 5 | 2019 | 3144 | 0.130 |
Why?
|
Pattern Recognition, Automated | 3 | 2016 | 996 | 0.130 |
Why?
|
Dexmedetomidine | 1 | 2020 | 315 | 0.130 |
Why?
|
Selenium | 4 | 2000 | 402 | 0.130 |
Why?
|
Vitamin A | 1 | 1998 | 615 | 0.130 |
Why?
|
Head Movements | 1 | 2016 | 150 | 0.130 |
Why?
|
Avitaminosis | 1 | 1995 | 34 | 0.130 |
Why?
|
Stroke | 3 | 2011 | 9963 | 0.130 |
Why?
|
Respiratory Distress Syndrome, Newborn | 3 | 2004 | 214 | 0.130 |
Why?
|
Observer Variation | 1 | 2021 | 2593 | 0.130 |
Why?
|
Maternal Welfare | 2 | 2013 | 115 | 0.120 |
Why?
|
Ferritins | 1 | 1997 | 590 | 0.120 |
Why?
|
Noise | 1 | 2017 | 279 | 0.120 |
Why?
|
Midwestern United States | 1 | 2014 | 70 | 0.120 |
Why?
|
Safety | 1 | 2019 | 1185 | 0.120 |
Why?
|
Putamen | 1 | 2015 | 291 | 0.120 |
Why?
|
Medical Errors | 1 | 2003 | 1296 | 0.120 |
Why?
|
Vitamin E | 3 | 1995 | 869 | 0.120 |
Why?
|
Auditory Cortex | 1 | 2018 | 346 | 0.120 |
Why?
|
Hyperglycemia | 1 | 2003 | 1368 | 0.120 |
Why?
|
Infant Mortality | 3 | 2010 | 754 | 0.120 |
Why?
|
Achievement | 1 | 2015 | 291 | 0.120 |
Why?
|
Sex Factors | 4 | 2018 | 10392 | 0.120 |
Why?
|
Blood Glucose | 1 | 2008 | 6249 | 0.120 |
Why?
|
Fixation, Ocular | 1 | 2015 | 247 | 0.120 |
Why?
|
Environmental Exposure | 3 | 2017 | 4231 | 0.120 |
Why?
|
Home Care Services | 2 | 2010 | 602 | 0.110 |
Why?
|
Thyroxine | 2 | 2014 | 666 | 0.110 |
Why?
|
Prefrontal Cortex | 2 | 2021 | 2146 | 0.110 |
Why?
|
Feeding and Eating Disorders of Childhood | 1 | 2013 | 37 | 0.110 |
Why?
|
Endocrine System | 1 | 2014 | 113 | 0.110 |
Why?
|
Logistic Models | 7 | 2021 | 13403 | 0.110 |
Why?
|
Blood Coagulation | 1 | 2019 | 1126 | 0.110 |
Why?
|
Visitors to Patients | 1 | 2013 | 35 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2017 | 11363 | 0.110 |
Why?
|
Anesthesia, General | 1 | 2020 | 1164 | 0.110 |
Why?
|
Axons | 2 | 2016 | 1681 | 0.110 |
Why?
|
Image Enhancement | 4 | 2016 | 2921 | 0.110 |
Why?
|
Brain Chemistry | 1 | 2016 | 981 | 0.110 |
Why?
|
Treatment Outcome | 11 | 2020 | 62966 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2026 | 0.110 |
Why?
|
Deglutition Disorders | 1 | 1998 | 604 | 0.110 |
Why?
|
Lythraceae | 1 | 2012 | 7 | 0.110 |
Why?
|
Intubation, Intratracheal | 2 | 2020 | 1357 | 0.110 |
Why?
|
Hydrolyzable Tannins | 1 | 2012 | 10 | 0.110 |
Why?
|
Blood Transfusion | 1 | 2019 | 1296 | 0.110 |
Why?
|
Nerve Net | 3 | 2016 | 2174 | 0.110 |
Why?
|
Odds Ratio | 7 | 2017 | 9846 | 0.110 |
Why?
|
Telencephalon | 2 | 2004 | 143 | 0.110 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2005 | 292 | 0.100 |
Why?
|
Social Adjustment | 2 | 2012 | 630 | 0.100 |
Why?
|
Melatonin | 1 | 2017 | 720 | 0.100 |
Why?
|
Verbal Learning | 2 | 2013 | 466 | 0.100 |
Why?
|
Adolescent | 16 | 2022 | 85649 | 0.100 |
Why?
|
Muscle Strength | 1 | 2016 | 586 | 0.100 |
Why?
|
Epilepsy | 2 | 2023 | 3301 | 0.100 |
Why?
|
Mental Disorders | 2 | 2013 | 6587 | 0.100 |
Why?
|
Chronic Disease | 6 | 2011 | 9144 | 0.100 |
Why?
|
Respiratory Rate | 1 | 2012 | 162 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2021 | 9941 | 0.100 |
Why?
|
Lactic Acid | 1 | 2016 | 1132 | 0.100 |
Why?
|
Case-Control Studies | 11 | 2020 | 21719 | 0.100 |
Why?
|
Affective Symptoms | 2 | 2015 | 407 | 0.100 |
Why?
|
Positive-Pressure Respiration | 3 | 2010 | 632 | 0.100 |
Why?
|
Facility Design and Construction | 1 | 2011 | 87 | 0.100 |
Why?
|
Patient Positioning | 1 | 2013 | 322 | 0.100 |
Why?
|
Periodicity | 1 | 2012 | 363 | 0.090 |
Why?
|
Paired-Associate Learning | 1 | 2010 | 52 | 0.090 |
Why?
|
Early Diagnosis | 3 | 2015 | 1184 | 0.090 |
Why?
|
Infant Equipment | 1 | 1990 | 24 | 0.090 |
Why?
|
Necrosis | 3 | 2021 | 1643 | 0.090 |
Why?
|
Trophoblasts | 1 | 2012 | 215 | 0.090 |
Why?
|
Risk | 3 | 2019 | 9679 | 0.090 |
Why?
|
Optic Nerve | 1 | 2013 | 548 | 0.090 |
Why?
|
Central Nervous System | 1 | 2017 | 1354 | 0.090 |
Why?
|
Radiography | 4 | 2007 | 7010 | 0.090 |
Why?
|
Aging | 5 | 2017 | 8626 | 0.090 |
Why?
|
Human Growth Hormone | 1 | 2015 | 683 | 0.090 |
Why?
|
Anxiety Disorders | 1 | 2021 | 2684 | 0.090 |
Why?
|
Remission, Spontaneous | 2 | 2002 | 380 | 0.090 |
Why?
|
Atrophy | 2 | 2006 | 1576 | 0.090 |
Why?
|
Cytokines | 1 | 2004 | 7317 | 0.090 |
Why?
|
Motor Activity | 4 | 2019 | 2714 | 0.090 |
Why?
|
Preoperative Period | 1 | 2011 | 546 | 0.090 |
Why?
|
Inflammation | 3 | 2021 | 10578 | 0.090 |
Why?
|
Hernia, Inguinal | 1 | 2011 | 202 | 0.090 |
Why?
|
Human Development | 1 | 2010 | 124 | 0.090 |
Why?
|
Dyskinesias | 1 | 2009 | 78 | 0.090 |
Why?
|
Social Behavior Disorders | 1 | 2009 | 97 | 0.090 |
Why?
|
High-Frequency Ventilation | 1 | 2009 | 87 | 0.090 |
Why?
|
Paternal Behavior | 1 | 2009 | 32 | 0.080 |
Why?
|
Demyelinating Diseases | 1 | 2011 | 363 | 0.080 |
Why?
|
Ibuprofen | 1 | 2010 | 235 | 0.080 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2010 | 371 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1967 | 0.080 |
Why?
|
Homeostasis | 1 | 2019 | 3335 | 0.080 |
Why?
|
Random Allocation | 2 | 2010 | 2425 | 0.080 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3510 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 3 | 2015 | 1847 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2966 | 0.080 |
Why?
|
Feeding Behavior | 3 | 2015 | 3187 | 0.080 |
Why?
|
Pyramidal Tracts | 1 | 2010 | 257 | 0.080 |
Why?
|
In Situ Nick-End Labeling | 1 | 2009 | 643 | 0.080 |
Why?
|
Adult | 15 | 2023 | 213712 | 0.080 |
Why?
|
Statistics, Nonparametric | 4 | 2013 | 2885 | 0.080 |
Why?
|
Disability Evaluation | 2 | 2012 | 1827 | 0.080 |
Why?
|
Mental Recall | 1 | 2014 | 1205 | 0.080 |
Why?
|
Continuous Positive Airway Pressure | 2 | 2010 | 546 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2022 | 3839 | 0.080 |
Why?
|
ROC Curve | 3 | 2021 | 3528 | 0.080 |
Why?
|
Purkinje Cells | 1 | 2009 | 223 | 0.080 |
Why?
|
Nerve Tissue Proteins | 2 | 2011 | 4465 | 0.080 |
Why?
|
Mesencephalon | 2 | 2007 | 327 | 0.080 |
Why?
|
Reaction Time | 1 | 2014 | 2092 | 0.070 |
Why?
|
Hospital Units | 2 | 2019 | 141 | 0.070 |
Why?
|
Parietal Lobe | 2 | 2019 | 837 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7901 | 0.070 |
Why?
|
Gyrus Cinguli | 1 | 2013 | 1088 | 0.070 |
Why?
|
Blood Proteins | 2 | 2004 | 1122 | 0.070 |
Why?
|
Ki-67 Antigen | 1 | 2009 | 644 | 0.070 |
Why?
|
Peer Group | 1 | 2012 | 635 | 0.070 |
Why?
|
Vision Disparity | 1 | 2006 | 27 | 0.070 |
Why?
|
Palliative Care | 1 | 2022 | 3478 | 0.070 |
Why?
|
Incidence | 2 | 2015 | 20928 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2010 | 2271 | 0.070 |
Why?
|
Pregnancy, Prolonged | 1 | 2006 | 9 | 0.070 |
Why?
|
Embryonic Development | 3 | 2007 | 704 | 0.070 |
Why?
|
Data Interpretation, Statistical | 2 | 2014 | 2714 | 0.070 |
Why?
|
Primates | 2 | 2009 | 543 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 2014 | 0.070 |
Why?
|
Motor Skills Disorders | 1 | 2006 | 90 | 0.070 |
Why?
|
Brain Waves | 1 | 2010 | 400 | 0.070 |
Why?
|
Brain Diseases, Metabolic | 1 | 2006 | 42 | 0.070 |
Why?
|
Diagnosis | 1 | 2007 | 154 | 0.070 |
Why?
|
Histocytochemistry | 1 | 2007 | 718 | 0.070 |
Why?
|
Cerebrospinal Fluid | 2 | 2006 | 534 | 0.070 |
Why?
|
Globus Pallidus | 1 | 2007 | 253 | 0.070 |
Why?
|
Respiration | 2 | 2009 | 1645 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2012 | 5062 | 0.070 |
Why?
|
Research Design | 2 | 2020 | 5979 | 0.070 |
Why?
|
Missouri | 2 | 2016 | 116 | 0.070 |
Why?
|
Hemiplegia | 1 | 2006 | 135 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12242 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 2 | 2011 | 3526 | 0.060 |
Why?
|
Problem Solving | 1 | 2008 | 440 | 0.060 |
Why?
|
Intelligence Tests | 2 | 2017 | 505 | 0.060 |
Why?
|
Nerve Fibers | 2 | 2013 | 688 | 0.060 |
Why?
|
Taurine | 1 | 2005 | 94 | 0.060 |
Why?
|
Transposition of Great Vessels | 1 | 2009 | 585 | 0.060 |
Why?
|
Resilience, Psychological | 1 | 2012 | 665 | 0.060 |
Why?
|
Transforming Growth Factor alpha | 1 | 2004 | 135 | 0.060 |
Why?
|
Saccades | 1 | 2006 | 245 | 0.060 |
Why?
|
Malondialdehyde | 2 | 2004 | 104 | 0.060 |
Why?
|
Pain | 1 | 2020 | 4961 | 0.060 |
Why?
|
Biological Evolution | 1 | 2010 | 1074 | 0.060 |
Why?
|
Parenteral Nutrition | 3 | 2000 | 650 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3306 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2009 | 1081 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2007 | 1104 | 0.060 |
Why?
|
Sheep | 1 | 2007 | 1437 | 0.060 |
Why?
|
Language Tests | 2 | 2017 | 200 | 0.060 |
Why?
|
Subarachnoid Space | 1 | 2004 | 79 | 0.060 |
Why?
|
Psychometrics | 1 | 2013 | 2999 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1659 | 0.060 |
Why?
|
Myelin Sheath | 3 | 2007 | 652 | 0.060 |
Why?
|
Sex Characteristics | 2 | 2017 | 2585 | 0.060 |
Why?
|
Anthropometry | 1 | 2008 | 1350 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2016 | 3527 | 0.060 |
Why?
|
Catheterization | 1 | 2009 | 1468 | 0.060 |
Why?
|
Cranial Sutures | 1 | 2004 | 93 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 1310 | 0.060 |
Why?
|
Disease Susceptibility | 1 | 2010 | 1780 | 0.060 |
Why?
|
Diet | 1 | 2021 | 7923 | 0.060 |
Why?
|
Learning | 1 | 2013 | 1705 | 0.060 |
Why?
|
Ambulances | 1 | 2003 | 95 | 0.060 |
Why?
|
Aspartic Acid | 2 | 2016 | 574 | 0.060 |
Why?
|
Phenytoin | 1 | 2023 | 197 | 0.060 |
Why?
|
Diagnostic Imaging | 2 | 2022 | 3507 | 0.060 |
Why?
|
Infant, Small for Gestational Age | 1 | 2005 | 440 | 0.050 |
Why?
|
Aircraft | 1 | 2003 | 123 | 0.050 |
Why?
|
Hernia, Diaphragmatic | 1 | 2004 | 250 | 0.050 |
Why?
|
Vermont | 2 | 2012 | 85 | 0.050 |
Why?
|
Craniosynostoses | 1 | 2007 | 400 | 0.050 |
Why?
|
Survival Analysis | 2 | 2014 | 10248 | 0.050 |
Why?
|
Placenta | 1 | 2012 | 1694 | 0.050 |
Why?
|
Diffusion | 1 | 2004 | 832 | 0.050 |
Why?
|
Evoked Potentials | 1 | 2008 | 1057 | 0.050 |
Why?
|
Consensus | 2 | 2023 | 2935 | 0.050 |
Why?
|
Gliosis | 3 | 2011 | 243 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.050 |
Why?
|
Fat Emulsions, Intravenous | 2 | 1996 | 321 | 0.050 |
Why?
|
Skull | 1 | 2007 | 810 | 0.050 |
Why?
|
Subtraction Technique | 2 | 2005 | 525 | 0.050 |
Why?
|
Internationality | 1 | 2008 | 1002 | 0.050 |
Why?
|
Intestines | 1 | 2011 | 1923 | 0.050 |
Why?
|
Neuroglia | 1 | 2008 | 925 | 0.050 |
Why?
|
Glutathione Peroxidase | 4 | 2000 | 255 | 0.050 |
Why?
|
Social Class | 1 | 2011 | 1995 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 26 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2004 | 689 | 0.050 |
Why?
|
Azides | 1 | 2021 | 116 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2009 | 1402 | 0.050 |
Why?
|
Causality | 1 | 2008 | 1265 | 0.050 |
Why?
|
Heart Rate | 1 | 2012 | 4091 | 0.050 |
Why?
|
Phlebography | 1 | 2022 | 333 | 0.050 |
Why?
|
Comorbidity | 3 | 2015 | 10372 | 0.050 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2000 | 363 | 0.050 |
Why?
|
Brain Edema | 1 | 2005 | 617 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4933 | 0.050 |
Why?
|
Socioeconomic Factors | 3 | 2013 | 7770 | 0.050 |
Why?
|
Labor, Obstetric | 1 | 2004 | 333 | 0.050 |
Why?
|
Confidence Intervals | 3 | 2011 | 2970 | 0.050 |
Why?
|
Child Health Services | 1 | 2006 | 667 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2022 | 451 | 0.050 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2012 | 194 | 0.050 |
Why?
|
Morbidity | 1 | 2005 | 1767 | 0.050 |
Why?
|
Preoperative Care | 1 | 2009 | 2245 | 0.040 |
Why?
|
Hospitalization | 2 | 2012 | 10232 | 0.040 |
Why?
|
Sleep | 2 | 2014 | 4604 | 0.040 |
Why?
|
Pneumothorax | 1 | 2003 | 379 | 0.040 |
Why?
|
Bangladesh | 1 | 2021 | 687 | 0.040 |
Why?
|
Length of Stay | 3 | 2020 | 6294 | 0.040 |
Why?
|
Periaqueductal Gray | 1 | 2000 | 107 | 0.040 |
Why?
|
Plethysmography | 1 | 2019 | 180 | 0.040 |
Why?
|
Neurosurgical Procedures | 1 | 2010 | 2002 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2009 | 10472 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 286 | 0.040 |
Why?
|
Interleukin-10 | 1 | 2004 | 1200 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2575 | 0.040 |
Why?
|
Rats | 5 | 2009 | 24265 | 0.040 |
Why?
|
Embryonic and Fetal Development | 1 | 2000 | 438 | 0.040 |
Why?
|
Cisapride | 1 | 1998 | 22 | 0.040 |
Why?
|
Societies, Scientific | 1 | 2020 | 220 | 0.040 |
Why?
|
Spinal Puncture | 1 | 2021 | 281 | 0.040 |
Why?
|
Neurons | 3 | 2011 | 9325 | 0.040 |
Why?
|
Ranitidine | 1 | 1998 | 34 | 0.040 |
Why?
|
Caregivers | 1 | 2010 | 2074 | 0.040 |
Why?
|
Pharyngeal Muscles | 1 | 1998 | 77 | 0.040 |
Why?
|
Young Adult | 4 | 2019 | 56350 | 0.040 |
Why?
|
Palate, Soft | 1 | 1998 | 96 | 0.040 |
Why?
|
Interview, Psychological | 1 | 2021 | 812 | 0.040 |
Why?
|
Heart Failure | 1 | 2002 | 10856 | 0.040 |
Why?
|
Diet Surveys | 1 | 2021 | 1172 | 0.040 |
Why?
|
Delphi Technique | 1 | 2020 | 778 | 0.040 |
Why?
|
Rats, Wistar | 3 | 2007 | 1902 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2003 | 934 | 0.040 |
Why?
|
Interleukins | 1 | 2021 | 791 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2010 | 3679 | 0.040 |
Why?
|
Umbilical Arteries | 1 | 2016 | 75 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 1 | 2019 | 732 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2004 | 3199 | 0.030 |
Why?
|
Bayes Theorem | 3 | 2012 | 2303 | 0.030 |
Why?
|
Suction | 1 | 1997 | 267 | 0.030 |
Why?
|
Analgesics | 1 | 2023 | 1037 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2016 | 381 | 0.030 |
Why?
|
Water | 1 | 2022 | 1388 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2012 | 12958 | 0.030 |
Why?
|
Mucus | 1 | 1997 | 321 | 0.030 |
Why?
|
Infant Food | 1 | 1995 | 141 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 725 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2004 | 3199 | 0.030 |
Why?
|
Infusions, Parenteral | 1 | 1995 | 415 | 0.030 |
Why?
|
Prevalence | 2 | 2009 | 15194 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2019 | 1179 | 0.030 |
Why?
|
Semantics | 1 | 2018 | 584 | 0.030 |
Why?
|
Cell Death | 1 | 2000 | 1695 | 0.030 |
Why?
|
United States | 4 | 2021 | 69693 | 0.030 |
Why?
|
Membrane Potentials | 1 | 2017 | 1135 | 0.030 |
Why?
|
Mathematics | 1 | 2015 | 727 | 0.030 |
Why?
|
Disease Management | 1 | 2005 | 2450 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1459 | 0.030 |
Why?
|
Dexamethasone | 1 | 2001 | 1949 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8541 | 0.030 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2014 | 238 | 0.030 |
Why?
|
Multiple Birth Offspring | 1 | 2013 | 21 | 0.030 |
Why?
|
Electromyography | 1 | 1998 | 1391 | 0.030 |
Why?
|
Intubation | 1 | 2013 | 141 | 0.030 |
Why?
|
Nutritional Status | 1 | 2021 | 1606 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1314 | 0.030 |
Why?
|
Memory, Long-Term | 1 | 2013 | 63 | 0.030 |
Why?
|
Muscle Hypotonia | 1 | 2013 | 165 | 0.030 |
Why?
|
Phototherapy | 1 | 1995 | 377 | 0.030 |
Why?
|
Eye Movements | 1 | 2015 | 506 | 0.030 |
Why?
|
Obesity | 1 | 2014 | 12705 | 0.030 |
Why?
|
Knowledge Bases | 1 | 2011 | 85 | 0.030 |
Why?
|
Growth Hormone | 1 | 2014 | 703 | 0.030 |
Why?
|
Artificial Intelligence | 1 | 2005 | 2187 | 0.030 |
Why?
|
Hemoglobins | 1 | 2017 | 1532 | 0.020 |
Why?
|
Cluster Analysis | 2 | 2011 | 2713 | 0.020 |
Why?
|
Radiation Protection | 1 | 1995 | 419 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2001 | 2107 | 0.020 |
Why?
|
Dietary Supplements | 2 | 2021 | 3294 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2948 | 0.020 |
Why?
|
Touch | 1 | 2013 | 306 | 0.020 |
Why?
|
Tissue Fixation | 1 | 2011 | 241 | 0.020 |
Why?
|
Organ Specificity | 1 | 2015 | 2003 | 0.020 |
Why?
|
Oxidation-Reduction | 3 | 2004 | 2187 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2003 | 2866 | 0.020 |
Why?
|
Massachusetts | 1 | 2023 | 8662 | 0.020 |
Why?
|
Boston | 2 | 2019 | 9305 | 0.020 |
Why?
|
Pulmonary Surfactants | 1 | 2010 | 161 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2012 | 280 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3766 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5180 | 0.020 |
Why?
|
Staining and Labeling | 2 | 2005 | 1099 | 0.020 |
Why?
|
Microglia | 2 | 2010 | 1261 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2000 | 2795 | 0.020 |
Why?
|
Papio papio | 1 | 2009 | 3 | 0.020 |
Why?
|
Middle Aged | 2 | 2022 | 213127 | 0.020 |
Why?
|
Tomography | 1 | 2011 | 388 | 0.020 |
Why?
|
Infant Welfare | 1 | 2009 | 82 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2019 | 1436 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19223 | 0.020 |
Why?
|
Light | 1 | 1995 | 1374 | 0.020 |
Why?
|
Weight Gain | 2 | 2014 | 2282 | 0.020 |
Why?
|
Inservice Training | 1 | 2011 | 392 | 0.020 |
Why?
|
Atlases as Topic | 1 | 2010 | 237 | 0.020 |
Why?
|
Somatostatin | 1 | 2010 | 459 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2017 | 3584 | 0.020 |
Why?
|
Ligation | 1 | 2009 | 453 | 0.020 |
Why?
|
Insulin | 1 | 2003 | 6575 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3740 | 0.020 |
Why?
|
Video Recording | 1 | 2013 | 944 | 0.020 |
Why?
|
Internal-External Control | 1 | 2009 | 363 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2013 | 763 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2011 | 690 | 0.020 |
Why?
|
Educational Status | 1 | 2015 | 2533 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2004 | 7276 | 0.020 |
Why?
|
Surface Properties | 1 | 2010 | 1182 | 0.020 |
Why?
|
Models, Neurological | 2 | 2006 | 1771 | 0.020 |
Why?
|
Schizophrenia | 1 | 2005 | 6874 | 0.020 |
Why?
|
Beverages | 1 | 2012 | 820 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2004 | 1574 | 0.020 |
Why?
|
Organogenesis | 1 | 2007 | 222 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1831 | 0.020 |
Why?
|
Canada | 1 | 2011 | 2061 | 0.020 |
Why?
|
Attitude | 1 | 1990 | 772 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 6030 | 0.020 |
Why?
|
Neocortex | 1 | 2009 | 400 | 0.020 |
Why?
|
Fluoresceins | 1 | 2005 | 234 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2011 | 941 | 0.020 |
Why?
|
Body Water | 1 | 2006 | 343 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2009 | 591 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 1990 | 819 | 0.020 |
Why?
|
Apoptosis | 2 | 2012 | 9715 | 0.010 |
Why?
|
Organic Chemicals | 1 | 2005 | 211 | 0.010 |
Why?
|
Skull Base | 1 | 2007 | 299 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 1123 | 0.010 |
Why?
|
Rosaniline Dyes | 1 | 2003 | 51 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2006 | 981 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 2008 | 780 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12946 | 0.010 |
Why?
|
Continuity of Patient Care | 1 | 2010 | 1048 | 0.010 |
Why?
|
Hyperinsulinism | 1 | 2006 | 415 | 0.010 |
Why?
|
Prosencephalon | 1 | 2004 | 303 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14554 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3571 | 0.010 |
Why?
|
Signal Transduction | 1 | 2004 | 23387 | 0.010 |
Why?
|
Social Support | 1 | 2011 | 2117 | 0.010 |
Why?
|
Hyaline Membrane Disease | 1 | 2000 | 19 | 0.010 |
Why?
|
Coloring Agents | 1 | 2003 | 565 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2005 | 748 | 0.010 |
Why?
|
Age Distribution | 1 | 2006 | 2900 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13814 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21821 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8621 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2011 | 5095 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 18112 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 8300 | 0.010 |
Why?
|
Proteomics | 1 | 2011 | 3618 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1990 | 2400 | 0.010 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 1997 | 49 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3862 | 0.010 |
Why?
|
Body Mass Index | 1 | 2014 | 12695 | 0.010 |
Why?
|
alpha 1-Antitrypsin | 1 | 1997 | 164 | 0.010 |
Why?
|
Macrophages | 1 | 2010 | 5655 | 0.010 |
Why?
|
Serine Proteinase Inhibitors | 1 | 1997 | 179 | 0.010 |
Why?
|
Jaundice, Neonatal | 1 | 1995 | 71 | 0.010 |
Why?
|
Glass | 1 | 1995 | 113 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1997 | 766 | 0.010 |
Why?
|
Aluminum | 1 | 1995 | 152 | 0.010 |
Why?
|
Plastics | 1 | 1995 | 123 | 0.010 |
Why?
|
Peroxidase | 1 | 1997 | 610 | 0.010 |
Why?
|
Growth | 1 | 1995 | 376 | 0.010 |
Why?
|
Pediatrics | 1 | 2008 | 3462 | 0.010 |
Why?
|
Specimen Handling | 1 | 1997 | 692 | 0.010 |
Why?
|
Plasma | 1 | 1995 | 575 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 24913 | 0.010 |
Why?
|
Computer Simulation | 1 | 2005 | 6191 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81045 | 0.010 |
Why?
|
Drug Interactions | 1 | 1995 | 1458 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 5100 | 0.010 |
Why?
|
Thyroid Gland | 1 | 1995 | 1172 | 0.010 |
Why?
|
Models, Biological | 1 | 2005 | 9581 | 0.000 |
Why?
|
Postoperative Complications | 1 | 2010 | 15244 | 0.000 |
Why?
|
Triglycerides | 1 | 1995 | 2450 | 0.000 |
Why?
|
Double-Blind Method | 1 | 2000 | 12017 | 0.000 |
Why?
|
Erythrocytes | 1 | 1995 | 2452 | 0.000 |
Why?
|
Proteins | 1 | 1997 | 6096 | 0.000 |
Why?
|
Membrane Proteins | 1 | 1997 | 7873 | 0.000 |
Why?
|